21 Aug Published on Aug 21, 2019 by pharmaffiliates Cinqair- A USFDA approved anti-asthmatic drug FDA, which is an agency within the U.S. Department of Health and Human Services, is responsible to protect the public health by assuring the safety, ... Read More
31 July Published July 31, 2019 by pharmaffiliates FAME Analysis-Critical for Nutritional Labeling Nutritional labeling is a cardinal task in today’s food industry, due to the stringent laws of government and FSSAI on food manufacturers.... Read More
25 July Published on July 25, 2019 by pharmaffiliates Women’s Health: Heart Disease Symptoms and Control It is estimated by the Centers for Disease Control and Prevention that one in four women in the world suffers from heart diseases. U.S. FDA helps women of all ages to learn how to use FDA-approved drugs and devices safely to prevent ... Read More
23 July Published on July 23, 2019 by pharmaffiliates The Necessity of Vitamin 12- A Global Concern It is estimated, that unknowingly more than 20% of the Indian population suffers from the deficiency of Vitamin 12 and suffer the consequences.... Read More
18 July Published on July 18, 2019 by pharmaffiliates We Expertise in Impurity Profiling at Pharmaffiliates It is necessary to assure that the observed pharmacologic or toxicological effects of a drug substance or Drug product are truly due to the compound of interest and not due to impurities. Furthermore, it is also important to ensure that the product formulated for marketing does not generate any impurities during its shelf life that would cause deleterious effects.... Read More
15 July Published July 15, 2019 by pharmaffiliates Amlodipine-A Little More Than a Calcium Channel Blocker Calcium Channel Blocker drugs are mainly known for the treatment of hypertension and angina. But, lesser it is known that Amlodipine which belongs to this category possess antioxidant activity and plays an important role in apoptosis... Read More
1 July Published on July 1, 2019 by Pharmaffiliates FAME Analysis-Critical for Nutritional Labeling Migraine – A most common brain disabling disorder is a condition characterized by the experience of migrainous headache on at least 15 days per month. Migraine has wide‐reaching implications for society, healthcare services, and the economy.. Read More
